IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q3 2020 Holdings

Filed 2020-11-13 | 8 holdings | $23.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axogen Inc(AXGN)COM05463X106$23.0M1,981,88899.3%
Revance Therapeutics Inc(RVNCEUR)COM761330109$84.0K3,342,0470.4%
Venus Concept, Inc.COM92332W105$28.8K12,417,8560.1%
Tela BIO, Inc.(TELA)COM872381108$24.4K1,475,2930.1%
Eyepoint Pharmaceuticals IncCOM30233G100$21.8K41,909,2190.1%
Medicinova Inc(MNOV)COM NEW58468P206$5.8K1,105,9410.0%
Catalyst Biosciences IncCOM NEW14888D208$33878,6220.0%
Endologix Inc(ELGXEUR)COM NEW29266S304$3125,7470.0%